GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » YoY EBITDA Growth

DuChemBio Co (XKRX:176750) YoY EBITDA Growth : 83.89% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. DuChemBio Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 83.89%.

DuChemBio Co's EBITDA per Share for the six months ended in Dec. 2023 was ₩419.02.

DuChemBio Co YoY EBITDA Growth Historical Data

The historical data trend for DuChemBio Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co YoY EBITDA Growth Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial -154.38 65.95 193.82 16.88 83.89

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial -154.38 65.95 193.82 16.88 83.89

DuChemBio Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

DuChemBio Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(419.022-227.864)/ | 227.864 |
=83.89 %

DuChemBio Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 ) |
=(419.022-227.864)/ | 227.864 |
=83.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DuChemBio Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

DuChemBio Co (XKRX:176750) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » YoY EBITDA Growth
Comparable Companies
XKRX:002620 XKRX:214390 XKRX:023910 XKRX:082800 XKRX:002390 XKRX:061250 XKRX:006620 XKRX:003120 XKRX:002210 XKRX:293780 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
Website
http://www.duchembio.com
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines